Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM (GinLivDM)
The Effects of Ginger on Biochemical Markers and Imaging Studies of Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (NAFLD)
Sponsor: Shiraz University of Medical Sciences
A EARLY_PHASE1 clinical study on Diabetes Mellitus, Type 2 and Fatty Liver, this trial is completed. The trial is conducted by Shiraz University of Medical Sciences and has accumulated 10 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed EARLY_PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Nov 2020 — Jan 2021 [monthly]
Completed EARLY_PHASE1
Status: Enrolling By Invitation → Completed
▶ Show 5 earlier versions
-
May 2019 — Nov 2020 [monthly]
Enrolling By Invitation EARLY_PHASE1
Status: Unknown Status → Enrolling By Invitation
-
Jun 2018 — May 2019 [monthly]
Unknown Status EARLY_PHASE1
-
Mar 2018 — Jun 2018 [monthly]
Unknown Status EARLY_PHASE1
Status: Active Not Recruiting → Unknown Status
-
Feb 2017 — Mar 2018 [monthly]
Active Not Recruiting EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting Phase 0
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Shiraz University of Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .